Search Result "Jak2-V617F"
The Use of Structural Biology in Janus Kinase Targeted Drug Discovery
Journal: Current Drug Targets
Volume: 12 Issue: 4 Year: 2011 Page: 546-555
Author(s): Nilda L. Alicea-Velazquez, Titus J. Boggon
JAK Inhibitors: Pharmacology and Clinical Activity in Chronic Myeloprolipherative Neoplasms
Journal: Current Medicinal Chemistry
Volume: 20 Issue: 9 Year: 2013 Page: 1147-1161
Author(s): J. Trelinski,T. Robak
The Recent Medicinal Chemistry Development of Jak2 Tyrosine Kinase Small Molecule Inhibitors
Journal: Current Medicinal Chemistry
Volume: 17 Issue: 3 Year: 2010 Page: 4551-4558
Author(s): R. Baskin, A. Majumder, P. P. Sayeski
JAK2 as a Molecular Marker in Myeloproliferative Diseases
Journal: Cardiovascular & Hematological Agents in Medicinal Chemistry
Volume: 5 Issue: 3 Year: 2007 Page: 198-203
Author(s): R. Mata, D. Subira, A. Garcia-Raso, P. Llamas
Insights into the Structural Features Essential for JAK2 Inhibition and Selectivity
Journal: Current Medicinal Chemistry
Volume: 23 Issue: 13 Year: 2016 Page: 1331-1355
Author(s): Chao Zhao,Daulat Bikram Khadka,Won-Jea Cho
JAK2 Inhibitors for Myelofibrosis: Why are They Effective in Patients with and Without JAK2V617F Mutation?
Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 12 Issue: 9 Year: 2012 Page: 1098-1109
Author(s): Fabio P. S. Santos,Srdan Verstovsek
An Update on JAK Inhibitors
Journal: Current Medicinal Chemistry
Volume: 26 Issue: 10 Year: 2019 Page: 1806-1832
Author(s): Francesca Musumeci,Chiara Greco,Ilaria Giacchello,Anna Lucia Fallacara,Munjed M. Ibrahim,Giancarlo Grossi,Chiara Brullo,Silvia Schenone
A Phenotypic Screen for Small-Molecule Inhibitors of Constitutively Active Mutant Thrombopoietin Receptor Implicated in Myeloproliferative Neoplasms
Journal: Combinatorial Chemistry & High Throughput Screening
Volume: 19 Issue: 10 Year: 2016 Page: 824-833
Author(s): Anna Ngo,Ann Zhufang Koay,Christian Pecquet,Carmen C. Diaconu,Yasmine Ould-Amer,Qiwei Huang,Congbao Kang,Anders Poulsen,May Ann Lee,David Jenkins,Andrew Shiau,Stefan N. Constantinescu,Meng Ling Choong
Molecular Pathogenesis of Philadelphia Chromosome Negative Chronic Myeloproliferative Neoplasms
Journal: Current Cancer Drug Targets
Volume: 11 Issue: 1 Year: 2011 Page: 20-30
Author(s): R. Jager, R. Kralovics
A Structure-Function Perspective of Jak2 Mutations and Implications for Alternate Drug Design Strategies: The Road not Taken
Journal: Current Medicinal Chemistry
Volume: 18 Issue: 3 Year: 2011 Page: 4659-4673
Author(s): K. Gnanasambandan, P.P. Sayeski